Medicare Enrolled
Dr. Humayun Jamidar, M.D.
Cardiovascular Disease · Daytona Beach, FL
Practice pattern: Electrophysiology & Cardiac— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jamidar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jamidar? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jamidar
Dr. Humayun Jamidar is a cardiovascular disease in Daytona Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Jamidar performed 16,702 Medicare services across 10,979 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jamidar received a total of $12,040 from 51 pharmaceutical and/or device companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jamidar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in FL$ $12,040 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,702
Medicare services
Top 2% in FL for cardiovascular disease
10,979
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~835 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead | 2,896 | $10 | $37 |
| Office visit, established patient (30-39 min) | 2,709 | $95 | $219 |
| Echocardiogram, transthoracic | 1,392 | $134 | $500 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,304 | $42 | $120 |
| Ultrasound of both sides of head and neck blood flow | 785 | $145 | $391 |
| Anticoagulant management of patient taking warfarin | 750 | $9 | $24 |
| Ultrasound of within the brain blood flow | 731 | $89 | $318 |
| EKG interpretation and report | 581 | $6 | $40 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 512 | $317 | $800 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 452 | $28 | $70 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 431 | $52 | $141 |
| Hospital follow-up visit, moderate complexity | 351 | $64 | $148 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 334 | $20 | $70 |
| Remote pacemaker/defibrillator monitoring, 90 days | 275 | $17 | $50 |
| Prothrombin time test (blood clotting) | 274 | $4 | $12 |
| New patient office visit (45-59 min) | 258 | $129 | $333 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 255 | $1,169 | $2,907 |
| Nuclear medicine study of heart muscle blood flow by pet | 231 | $141 | $342 |
| Remote pacemaker monitoring, 90 days | 214 | $23 | $65 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 209 | $624 | $1,357 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 208 | $20 | $56 |
| Ultrasound scan of abdominal aorta | 205 | $103 | $223 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 198 | $171 | $215 |
| Programming of dual lead pacemaker system | 184 | $48 | $143 |
| Initial hospital admission, moderate complexity | 170 | $105 | $283 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 122 | $19 | $66 |
| Office visit, established patient, complex (40-54 min) | 105 | $140 | $294 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 102 | $327 | $928 |
| Programming of cardiac rhythm monitor system | 71 | $37 | $107 |
| Evaluation of implantable heart and blood vessel monitoring system | 64 | $28 | $94 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 60 | $28 | $79 |
| Programming of single lead pacemaker system | 56 | $43 | $121 |
| Limited ultrasound scan behind abdominal cavity | 50 | $45 | $117 |
| Programming of dual lead implantable defibrillator system | 40 | $57 | $184 |
| Ultrasound of heart, follow-up | 33 | $73 | $194 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 33 | $19 | $52 |
| Programming of multiple lead implantable defibrillator system | 21 | $62 | $199 |
| New patient office visit, complex (60-74 min) | 13 | $175 | $421 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 12 | $20 | $55 |
| Heart rhythm recording of continous external ekg over 8-15 days | 11 | $9 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.6% high complexity
24.7% medium
61.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,040
Total received (2018-2024)
Avg $1,720/year across 7 years
Top 21% in FL for cardiovascular disease
51
Companies
513
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,040 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,339
2023$1,845
2022$1,569
2021$1,943
2020$1,010
2019$1,765
2018$2,569
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$1,621
Amgen Inc.
$1,110
Novartis Pharmaceuticals Corporation
$889
ABIOMED
$879
Boston Scientific Corporation
$857
Cardiovascular Systems Inc.
$692
Boehringer Ingelheim Pharmaceuticals, Inc.
$576
E.R. Squibb & Sons, L.L.C.
$563
AstraZeneca Pharmaceuticals LP
$537
SANOFI-AVENTIS U.S. LLC
$523
Medtronic Vascular, Inc.
$432
PFIZER INC.
$363
CVRx, Inc.
$343
Alnylam Pharmaceuticals Inc.
$311
Novo Nordisk Inc
$249
Amarin Pharma Inc.
$249
Abbott Laboratories
$219
Esperion Therapeutics, Inc.
$203
Shockwave Medical, Inc
$162
Cleerly, Inc.
$147
Merck Sharp & Dohme LLC
$143
Lilly USA, LLC
$101
Regeneron Healthcare Solutions, Inc.
$83
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$81
Kiniksa Pharmaceuticals, Ltd.
$68
Kiniksa Pharmaceuticals International, plc
$52
BOSTON SCIENTIFIC CORPORATION
$42
Bayer HealthCare Pharmaceuticals Inc.
$41
Braemar Manufacturing, LLC
$40
Impulse Dynamics (USA) Inc.
$39
Edwards Lifesciences Corporation
$34
Lexicon Pharmaceuticals, Inc.
$34
ShockWave Medical, Inc
$26
Merck Sharp & Dohme Corporation
$25
Bardy Diagnostics, Inc.
$24
SCPHARMACEUTICALS INC.
$24
Philips Electronics North America Corporation
$23
Astellas Pharma US Inc
$22
Kowa Pharmaceuticals America, Inc.
$22
Philips North America LLC
$21
Lundbeck LLC
$19
Daiichi Sankyo Inc.
$18
iRhythm Technologies, Inc.
$17
Chiesi USA, Inc.
$16
PORTOLA PHARMACEUTICALS, INC.
$15
PORTOLA PHARMACEUTICALS, LLC
$15
LivaNova USA, Inc.
$15
Gilead Sciences, Inc.
$14
Medtronic, Inc.
$14
GENZYME CORPORATION
$13
ARALEZ PHARMACEUTICALS US INC.
$11
Top 3 companies account for 30.1% of total payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (CK7) Extended Holter · AMPLATZER AMULET · ANDEXXA · AVEIR · Advisa · Arcalyst · Azure · BEVYXXA · BRILINTA · Barostim Neo System · CAMZYOS · CHANTIX · CONFIRM RX · CROSSBOSS · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink Express · Carnation Ambulatory Monitor · Claria MRI · Cleerly Ischemia · Confirm Rx · Consulta · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · Diamondback Coronary · Diamondback Peripheral · DxTerity · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · INJECTAFER · Impella · Inpefa · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LifeVest · Livalo · MOUNJARO · MULTAQ · NEXLETOL · NORTHERA · ONPATTRO · Optimizer Smart System · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROTEKDUO · Peripheral Orbital Atherectomy System · QT Vascular Chocolate PTA Balloon · Quadra Assura CRT Defibrillator · Repatha · Resolute · Reveal LINQ · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · Saxenda · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TYRX · VERQUVO · Vascepa · Vascular Lithotripsy · VersaCross Access Solution · Visia AF · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · ZIO Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $72 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
32
Per 100K population
5.6
County median income
$66,581
Nearest hospital
HALIFAX HEALTH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Jamidar is a electrophysiology & cardiac specialist, with above-average Medicare volume (top 2% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Jamidar experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Jamidar performed 2,896 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jamidar receive payments from pharmaceutical companies?
Yes. Dr. Jamidar received a total of $12,040 from 51 companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jamidar's costs compare to other cardiovascular diseases in Daytona Beach?
Dr. Jamidar's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jamidar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Daytona Beach
Browse cardiovascular diseases in Daytona Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology